Rare Diseases
From the Journals
JIA disease activity, disability linked to social factors
For patients with polyarticular juvenile idiopathic arthritis, levels of disease activity and disability vary, depending on family income,...
Latest News
Early puberty cases among girls surged during pandemic
Doctors have tied the current uptick to the stress of the pandemic and lockdowns, including reduced physical activity and increased consumption of...
From the Journals
IV gentamicin improves junctional epidermolysis bullosa in children
After treatment, each of the children had increased, sustained expression of laminin 332.
Conference Coverage
Dupilumab treats itch and clears lesions in prurigo nodularis patients
There are currently no Food and Drug Administration–approved systemic therapies for PN.
Conference Coverage
Novel isotretinoin ointment for congenital ichthyosis shows promise
“There is currently no FDA-approved drug for congenital ichthyosis,” Dr. Christopher G. Bunick said.
Guidelines
Kawasaki disease guideline highlights rheumatology angles
“This guideline approaches Kawasaki disease from a perspective of acting as an adjunct to the already existing and excellent...
Guidelines
New JIA guidelines emphasize earlier DMARD use
Advances in understanding and treating systemic JIA have led practitioners away from steroids and toward using conventional synthetic and biologic...
Latest News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
Guidelines
New MIS-C guidance addresses diagnostic challenges, cardiac care
New updates in this third version of the American College of Rheumatology’s guidance include a recommendation for dual therapy with IVIg and...
Commentary
Growth hormone therapy for certain children may help them reach their potential
When should parents consider growth hormone therapy? In what cases is it warranted for children? Dr. Jessica Sparks Lilley discusses the need for...
Feature
Cystic fibrosis in retreat, but still unbeaten